Christopher A Slapak Selected Research

Christopher A Slapak Research Topics

9	Neoplasms (Cancer) 01/2017 - 12/2002
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2015 - 03/2012
2	Fatigue 03/2012 - 09/2011
2	Breast Neoplasms (Breast Cancer) 03/2004 - 01/2002
1	Anemia 01/2017
1	Cardiotoxicity 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Thrombocytopenia (Thrombopenia) 06/2013
1	Disseminated Intravascular Coagulation 06/2013
1	Chills 03/2012
1	Diarrhea 09/2011
1	Nausea 09/2011
1	Vomiting 09/2011
1	Fever (Fevers) 09/2011
1	Anorexia 09/2011
1	Disease Progression 05/2007
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2004
1	Leukemia 01/2002

4	Gemcitabine FDA Link 06/2013 - 06/2004
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2004 - 01/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2004 - 01/2002
2	Monoclonal AntibodiesIBA 01/2017 - 01/2015
2	ocaratuzumabIBA 01/2015 - 03/2012
2	Transaminases (Aminotransferases)IBA 06/2013 - 09/2011
2	LY2334737IBA 06/2013 - 09/2011
2	ProdrugsIBA 06/2013 - 09/2011
2	zosuquidar trihydrochloride (LY335979)IBA 05/2004 - 12/2002
2	Proteins (Proteins, Gene)FDA Link 03/2004 - 01/2002
1	metal transporting protein 1 (ferroportin)IBA 01/2017
1	HepcidinsIBA 01/2017
1	LY2787106IBA 01/2017
1	IronIBA 01/2017
1	LY-2157299IBA 01/2015
1	NivolumabIBA 01/2015
1	BilirubinIBA 06/2013
1	N- ((5- bromo- 2- thienyl)sulfonyl)- 2,4- dichlorobenzamideIBA 11/2011
1	SodiumIBA 11/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2011
1	EnzymesIBA 09/2011
1	enzastaurinIBA 05/2007
1	Protein Kinase C betaIBA 05/2007
1	Docetaxel (Taxotere)FDA Link 11/2004
1	AntimetabolitesIBA 06/2004
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2004
1	LY 475776IBA 03/2004
1	Fluorouracil (Carac)FDA LinkGeneric 01/2002
1	Etoposide (VP 16)FDA LinkGeneric 01/2002
1	multidrug resistance-associated protein 1IBA 01/2002
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2002

2	Therapeutics 06/2008 - 05/2004
1	Oral Administration 06/2008